AzTrials
AzTrials

Urinary IncontinenceNCT07603388

Effects of Pelvic Floor Rehab Protocol on Urinary Incontinence

A study testing Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group and Standard Protocol for Pelvic floor strengthening in people with Urinary Incontinence, run by Riphah International University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Urinary incontinence is a serious health issue that deeply affects a person's daily life and overall well-being. The global prevalence of UI is between 5 to 69% during a woman's lifetime, with higher prevalence in older age groups. Read more about this study

Who is it for?
Ages 18 to 35 years, women only
Conditions the study is for
Urinary Incontinence
What is being tested?
Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group and Standard Protocol for Pelvic floor strengthening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 sitePakistan
Study dates
1 Nov 2025to 30 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Pregnant women aged 18-35 yrs.
  • Score ≥1 on stress or urge subscale of the Questionnaire for Incontinence Diagnosis
  • No participation in a structured pelvic floor rehabilitation program within the last six months.

Who cannot join

  • • Patients with High-risk pregnancy.
  • Known neurological disorders.
  • History of pelvic surgery.
  • ACOG Contraindications for Exercise

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Riphah International Hospital

    Islamabad, Islamabad, 44000

Other trials in Pakistan

About this study

Official title: Effects of Pregnancy Specific Pelvic Floor Rehab Protocol on Urinary Incontinence

Urinary incontinence is a serious health issue that deeply affects a person's daily life and overall well-being. The global prevalence of UI is between 5 to 69% during a woman's lifetime, with higher prevalence in older age groups. The goal of this randomized controlled trial is to compare the effects of pregnancy specific pelvic floor rehab protocol with the standard protocol on urinary incontinence. Participants will be randomly assigned to one of the two groups. The results of this trial would be helpful in this way that how Pregnancy specific pelvic floor rehab protocol can provide support for pregnant ladies with urinary incontinence and improve health outcomes.

Read the detailed description

The International Continence Society defines urinary incontinence as the 'unintentional or involuntary leakage of urine'. Urinary incontinence is a serious health issue that deeply affects a person's daily life and overall well-being. It can be physically exhausting and emotionally overwhelming, often leading to embarrassment, loss of confidence, and feelings of helplessness. Many people dealing with it also struggle with anxiety and depression, as it limits their freedom and makes even simple daily tasks feel challenging. Urinary incontinence (UI) is common during pregnancy with prevalence rates of 31% in nulliparous women and 42% in parous women. The global prevalence of UI is between 5 to 69% during a woman's lifetime, with higher prevalence in older age groups. . Urinary incontinence during pregnancy affects women's physical comfort, emotional well-being, and quality of life, yet it remains under-identified and undertreated in standard antenatal care. Although pelvic floor exercises are widely recommended, most existing programs are not adapted to the unique demands of pregnancy. A structured, pregnancy-specific pelvic floor rehabilitation protocol can address these needs more effectively by offering trimester-based guidance, functional training, and education. . This pregnancy-specific pelvic floor rehabilitation protocol follows a progressive 4-week plan focused on pelvic floor muscle training, core activation, and functional strengthening. Exercises such as Kegels, abdominal drawing-in, bridging, and clamshells are performed in various positions with controlled breathing. Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education. Participants will be randomly assigned through convenient sampling method to each groups. Ethical considerations will be completely taken and data will be analyzed through SPSS version 26. This study aims to evaluate the impact of such a protocol and provide evidence to support its integration into routine prenatal care, potentially improving maternal outcomes and long-term recovery.

Being tested
Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group, Standard Protocol for Pelvic floor strengthening
Keywords
Pregnancy Specific Pelvic Floor Rehab Protocol, Pregnant Women, Urinary Incontinence
Medical subject headings
Urinary Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pregnancy Specific Pelvic floor rehab protocol (PSPFR) GroupOther

    This pregnancy-specific pelvic floor rehabilitation protocol follows a progressive 4-week plan focused on pelvic floor muscle training, core activation, and functional strengthening. Exercises such as Kegels, abdominal drawing-in, bridging, and clamshells are performed in various positions with controlled breathing. Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education. The instructions of the supervised exercises would be Hold for 2 s in 3 repetitions, 5 seconds rest, 1 minute of rest between each exercise \& 2 sets each. The record of each session will be written in diaries.

  • Standard Protocol for Pelvic floor strengtheningOther

    in this group, standard exercises used for strengthening of pelvic floor to prevent urinary incontinence will be implemented.

Study groups in NCT07603388
Study groupRoleWhat they receive
Pregnancy Specific Pelvic floor Rehab Protocol (PSPFR) Group (2nd Trimester)ExperimentalThis group will receive a pregnancy-specific supervised pelvic floor rehabilitation protocol and basic antenatal education. There will be 2 sessions per week for 4 weeks. Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
Receives: Other: Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group
Pregnancy Specific Pelvic floor Rehab Protocol (PSPFR) Group (3rd Trimester)ExperimentalThis group will receive a pregnancy-specific supervised pelvic floor rehabilitation protocol and basic antenatal education. There will be 2 sessions per week for 4 weeks. Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
Receives: Other: Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group
Standard Pelvic floor Rehab Protocol GroupActive comparatorThis group receives standard protocol for strengthening of pelvic floor to prevent urinary incontinence.
Receives: Other: Standard Protocol for Pelvic floor strengthening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Questionnaire for Incontinence Diagnosis

    The Questionnaire for Incontinence Diagnosis is a self-reported screening tool used to identify the presence and type of urinary incontinence, such as stress, urge, or mixed incontinence. It consists of structured questions related to symptom triggers, frequency, and leakage patterns. Each item scores 0 (None of the time), 1 (Rarely), 2 (Once in a while), 3 (Often), 4 (Most of the time) or 5 (All of the time). Responses to items 1, 2 and 3 are summed for the Stress score; and responses to items 4, 5, and 6 are summed for the Urge score.

    Measured: 4 weeks

Secondary outcomes (4)
  1. Incontinence Severity Index

    The ISI is a quick, two-question tool that assesses the frequency and amount of urine leakage. Scores range from 0 to 12, indicating severity from none to very severe. It is simple to administer and useful for tracking symptom changes over time.

    Measured: 4 weeks

  2. International Consultation on Incontinence Questionnaire (ICIQ-UI-SF)

    The ICIQ-UI-SF is a validated self-reported questionnaire that assesses the frequency, severity, and impact of urinary incontinence. Scores range from 0 to 21, with higher scores indicating greater symptom severity and quality-of-life impact. It is widely used to quantify the patient-reported burden of incontinence.

    Measured: 4 weeks

  3. Incontinence Impact Questionnaire

    The IIQ-7 assesses the psychosocial and functional impact of urinary incontinence on daily life, including physical activity, travel, and emotional well-being. Scores range from 0 to 100, with higher scores reflecting a greater negative impact. It is a useful tool for evaluating quality of life related to incontinence.

    Measured: 4 weeks

  4. Patient Global Impression of Improvement Scale

    The PGI-I is a single-item scale that captures the patient's overall perception of symptom improvement after treatment. It reflects subjective satisfaction with the intervention. The 7-point scale ranges from 1 (very much better) to 7 (very much worse), with lower scores indicating greater improvement.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2026
  2. Study start1 Nov 2025
  3. Primary completion7 May 2026
  4. Study completion30 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
There will be comparison between experimental group and control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07603388
Sponsor's protocol ID
Attiya Azhar
Status last verified
Jul 2026
First submitted
18 May 2026
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wu Y, Li T, Cai F, Ye X, Xu M. Stable pelvic floor muscle training improves urinary incontinence in women with gestational diabetes mellitus. J Obstet Gynaecol. 2024 Dec;44(1):2420192. doi: 10.1080/01443615.2024.2420192. Epub 2024 Oct 30.

    PubMed 39473377
  • Kamali S, Ozengin N, Topcuoglu MA. The effect of e-pelvic floor muscle training on symptoms in women with stress urinary incontinence: a randomized controlled trial. Women Health. 2023 Jul 3;63(6):473-483. doi: 10.1080/03630242.2023.2223729. Epub 2023 Jun 14.

    PubMed 37315962

Questions about this trial

What is this clinical trial studying?

A study testing Pregnancy Specific Pelvic floor rehab protocol (PSPFR) Group and Standard Protocol for Pelvic floor strengthening in people with Urinary Incontinence, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Questionnaire for Incontinence Diagnosis (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07603388, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in